Tappeiner, ChristophChristophTappeiner0000-0001-6907-1112Heinz, CarstenCarstenHeinzSpecker, ChristofChristofSpeckerHeiligenhaus, ArndArndHeiligenhaus2024-10-142024-10-142007https://boris-portal.unibe.ch/handle/20.500.12422/114169BACKGROUND To report on anti-CD20 antibody therapy in a patient with uveitis refractive to immunosuppression therapy. METHODS Case report with ophthalmoscopic, optical coherence tomography and fluorescein-angiographic findings. RESULTS A 49-year-old woman was suffering from bilateral, noninfectious chronic anterior uveitis refractive to corticosteroids and immunosuppressive drugs. Bilateral visual acuity was 20/100 due to cataract and cystoid macular edema (CME). After treatment with rituximab, vision and CME improved, and uveitis was stable until the final visit (follow-up at 12 months). CONCLUSION The case report suggests that rituximab may be helpful for selected patients with chronic anterior uveitis refractive to corticosteroids and immunosuppressive medication.en600 - Technology::610 - Medicine & healtharticle10.7892/boris.428941753411910.1159/000103239